A new study by researchers at NYU Langone Medical Center indicates that consumers are more interested in using genetic technologies to screen for life threatening diseases than in using the technologies to screen offspring for enhanced traits. Specifically, consumers appear ready to use biotechnologies to test for life altering and threatening medical conditions like mental retardation, blindness, deafness, cancer, heart disease, dwarfism and shortened lifespan from death by 5 years of age—but what they’re not interested in is prenatal genetic testing to screen for traits like tall stature, superior athletic ability and superior intelligence. “Our research has discovered that although...